Literature DB >> 1064679

Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.

D S Chervinsky, J J Wang.   

Abstract

The uptake of Adriamycin (AM) and Daunomycin (DM) in L1210 leukemia cells was found to be dependent on drug dose, time, and temperature. DM was taken up to a greater extent in human leukemia cells in vitro and in L1210 leukemic cells both in vitro and in vivo. Intracellular retention of DM was less than that of AM. Drug transport appears to be a factor in developing resistance to DM in L1210 cells, but the data for AM were inconclusive in this regard. The importance of cellular uptake and retension operative in determining differences in the overall therapeutic efficacy in vivo remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1064679

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  9 in total

1.  Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.

Authors:  S Seeber; H Loth
Journal:  Blut       Date:  1981-06

2.  In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumor.

Authors:  T Skovsgaard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

3.  Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.

Authors:  V Trillet; M Lakhal; J Lang; E Perrin-Fayolle; Q Timour Chah; D Fière; G Faucon
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer.

Authors:  B K Chang; J A Gregory
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.

Authors:  C Paul; C Peterson; G Gahrton; D Lockner
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Uptake of adriamycin by human leukemic cells as measured by flow cytometry.

Authors:  H D Preisler; A Raza
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Doxorubicin concentrations in plasma and myocardium and their respective roles in cardiotoxicity.

Authors:  Q Timour; P Nony; J Lang; M Lakhal; V Trillet; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

9.  Reversal of natural resistance to bouvardin (NSC 259968) in sarcoma 180 cells in vitro and in vivo by verapamil.

Authors:  M P Chitnis; R S Menon; V S Basrur; M K Adwankar; K Satyamoorthy
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.